Pfizer’s VC arm has backed a $100 million series A raise for OTR Therapeutics as the Chinese biotech tacks on preclinical ...
The WorkBoss CT is available in 18x8.50-10 and 26x12.00-12, with additional sizes planned in the coming months.
Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (IV) to ...
OTR is a $107 million SPAC led by veteran investor and entrepreneur Nicholas J. Singer, who serves as Chairman and Chief Executive Officer. The team is comprised of growth-oriented executives with a ...
The patented Eagle OTR Debeader is designed to safely and efficiently pull both beads from the same side without flipping the ...
HANOVER, Germany—Cabot Corp. has developed an engineered elastomer composite that it claims can extend the life of OTR/earthmover tires "significantly" while cutting processing costs for tire ...
More are looking for that elusive goal of work-life balance with healthy profits and maximum time efficiency on the road to justify time spent on other pursuits. In this webinar — sponsored by ...
A woman in Over-the-Rhine nearly lost her life Tuesday taking her dog out for a walk. She was hit as a high-speed chase from Southgate, Kentucky, came across the river and came to a crashing stop at ...
Above and below find 2024's third mid-week special edition in Overdrive Radio's series of Partners in Business shorts culled from a long owner-operator business-focused talk at the Mid-America ...
The building that used to house the Mercer OTR is getting new life.The owners of Crown Restaurant Group, which owns Crown Republic Gastropub, Losanti, Rosie’s Cocktails and Pies and most recently La ...
WOBURN, Mass. & MIAMI--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and ...
WOBURN, Mass. & MIAMI--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, ...